Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -158,100 | -198,644 | -77,758 | -59,788 | N/A |
| Depreciation Amortization | 21,400 | 14,998 | 11,091 | 5,722 | N/A |
| Accounts receivable | 93,800 | 99,336 | 86,977 | 96,734 | N/A |
| Accounts payable and accrued liabilities | 14,100 | 8,024 | 19,285 | 22,796 | N/A |
| Other Working Capital | 18,400 | 61,525 | 97,124 | 94,045 | N/A |
| Other Operating Activity | -133,600 | -47,194 | -122,852 | -143,991 | 0 |
| Operating Cash Flow | $-144,000 | $-61,955 | $13,867 | $15,518 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -149,200 | 1,544,669 | N/A | N/A | N/A |
| PPE Investments | -14,100 | -11,727 | -9,662 | -6,245 | N/A |
| Other Investing Activity | -687,300 | -2,295,644 | -1,082,117 | -389,903 | 0 |
| Investing Cash Flow | $-850,600 | $-762,702 | $-1,091,779 | $-396,148 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,700 | 9,113 | 3,704 | 1,589 | N/A |
| Other Financing Activity | -4,000 | -3,082 | -1,918 | -758 | 0 |
| Financing Cash Flow | $5,700 | $6,031 | $1,786 | $831 | $N/A |
| Exchange Rate Effect | -2,100 | 190 | -334 | -343 | N/A |
| Beginning Cash Position | 1,277,700 | 1,277,713 | 1,277,713 | 1,277,713 | N/A |
| End Cash Position | 286,700 | 459,277 | 201,253 | 897,571 | N/A |
| Net Cash Flow | $-991,000 | $-818,436 | $-1,076,460 | $-380,142 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -144,000 | -61,955 | 13,867 | 15,518 | N/A |
| Capital Expenditure | -14,100 | -11,727 | -9,662 | -6,243 | N/A |
| Free Cash Flow | -158,100 | -73,682 | 4,205 | 9,275 | 0 |